Q2i wins 2026 Northeast USA Company of the Year for digital health

Q2i has been named the 2026 Northeast USA Company of the Year for Digital Health Solution by the Excellence Awards, which cited the Boston company’s innovation, ethics and market impact. The honor highlights growing adoption of Q2i’s evidence-based platforms, including tools used to scale contingency management programs across clinics and public agencies.

Why it matters: - The award spotlights demand for digital health tools that can move evidence-based care from research into routine use. - Q2i’s recognition also underscores growing interest in scalable platforms for behavioral health, substance use disorder treatment, chronic disease prevention and community supervision. - The company’s contingency management technology already supports more than 15,000 patients and beneficiaries across more than 160 clinics.

What happened: - Q2i was named 2026 Northeast USA Company of the Year for Digital Health Solution by the Excellence Awards. - The Boston-based company was recognized on Sept. 22, 2026. - The Excellence Awards evaluated organizations on innovation, ethical standards, market impact, customer value and contribution to the industry. - Steven Jenkins, Q2i founder and CEO, said the award reflects work to turn behavioral science into practical technology that improves care at scale.

The details: - Q2i was founded in 2016 and develops digital health platforms with healthcare providers, government agencies, payers, researchers and academic partners. - The company focuses on regulated environments where security, usability, fidelity and measurable outcomes matter. - A major area of Q2i’s work is Contingency Management, an evidence-based behavioral intervention that uses incentives to reinforce verified positive behaviors, including treatment participation and abstinence from substance use. - Contingency Management Innovations, or CMI, builds technology that helps healthcare organizations and government agencies implement and manage contingency management programs at scale. - CMI platforms automate incentive schedules, reward calculation and delivery, participant communications, access controls and reporting. - Janus supports provider-led programs. - The State Incentive Management System, or SIMS, is designed for large multi-site initiatives run by state, county and city health departments. - Q2i says the technology reduces administrative burden while supporting consistency, oversight and fidelity to evidence-based protocols. - Q2i’s honors in 2026 also include HealthTech Company of the Year in the Corporate LiveWire Global Awards 2025/26. - The company also won a Gold Stevie Award for Achievement in Technology Innovation at the 2026 American Business Awards. - Jenkins received a Silver Stevie Award for Entrepreneur — Health Products & Services. - Q2i will be featured in the Excellence Awards Magazine and added to the organization’s permanent Hall of Fame A–Z listing. - More information is available on Q2i’s website, Contingency Management Innovations, LinkedIn and YouTube.

Between the lines: - The award adds third-party validation to a company operating in a niche but increasingly important corner of digital health. - Q2i’s emphasis on compliance, verification and program fidelity suggests its products are built for organizations that need clinical rigor and administrative control, not just patient engagement. - The CMI platforms appear positioned for public-sector use cases, where scale and oversight are often as important as individual treatment support.

What's next: - Q2i is set to gain additional visibility through the Excellence Awards Magazine and Hall of Fame listing. - The company is likely to continue leaning on contingency management and other evidence-based digital health tools as adoption grows across provider and public-agency settings. - CMI’s current footprint suggests further expansion could come from additional clinics, health departments and other regulated care settings.